Statement Of Financial Position [Abstract]

HEMOGENYX PHARMACEUTICALS PLC - Filing #5969073

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
759,408 GBP
966,423 GBP
Right-of-use assets
1,967,813 GBP
2,346,015 GBP
Intangible assets other than goodwill
477,403 GBP
470,173 GBP
Cash and cash equivalents
159,265 GBP
1,247,601 GBP
2,532,758 GBP
Assets
4,211,560 GBP
6,105,893 GBP
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
35,045 GBP
11,755,660 GBP
Retained earnings
29,423,915 GBP
23,804,734 GBP
Share premium
21,388,546 GBP
19,938,556 GBP
Other reserves
1,508,572 GBP
1,164,637 GBP
Equity attributable to owners of parent
897,514 GBP
2,818,729 GBP
Non-controlling interests
44,020 GBP
37,723 GBP
Equity
29,423,915 GBP
21,388,546 GBP
35,045 GBP
44,020 GBP
435,955 GBP
1,508,572 GBP
6,157,894 GBP
13,983,115 GBP
853,494 GBP
2,781,006 GBP
23,804,734 GBP
1,164,637 GBP
37,723 GBP
19,938,556 GBP
11,755,660 GBP
- GBP
77,496 GBP
6,157,894 GBP
3,243,520 GBP
921,801 GBP
31,908 GBP
16,808,647 GBP
17,114,056 GBP
9,797,493 GBP
6,157,894 GBP
- GBP
980,563 GBP
Liabilities [abstract]
Liabilities
3,358,066 GBP
3,324,887 GBP
Equity and liabilities
4,211,560 GBP
6,105,893 GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.